Key result
Pocket hematoma is linked to ~440% higher risk of device-associated infection.
Why the study?
Implantable cardiac device infection increases morbidity, mortality, and healthcare burden, making the identification of modifiable risk factors essential to prevent infection and avoid extraction.
What are the incidence and risk factors for cardiac implantable electronic device infections?
Cohort (n=2,202)
No
What are the incidence and risk factors for cardiac implantable electronic device infections?
Answers are grounded in this paper and cite their sources.
Hematoma formation and prolonged procedure duration are independent predictors of CIED infection, highlighting the importance of meticulous procedural technique.
Background Implantable cardiac devices are widely used for rhythm disorders, yet infection remains one of the most serious complications, increasing morbidity, mortality, and healthcare burden. Identifying modifiable risk factors is essential to prevent infection and avoid extraction. Purpose To determine infection incidence and evaluate clinical and procedural risk factors associated with implantable cardiac electronic device infections. Methods A retrospective cohort of consecutive patients receiving permanent pacemakers, defibrillators, or generator/lead replacement procedures (2014–2023) was evaluated. Demographic data, comorbidities, medications, laboratory findings, procedural characteristics (device type, number of leads, duration, need for temporary pacing, re-intervention, hematoma), and microbiological results were analyzed. Infection was defined as local pocket infection or systemic involvement confirmed clinically and microbiologically. Univariate and multivariate logistic regression and Cox analysis were performed. Results Among 2,202 procedures, 113 patients (4.8%) developed device-associated infection. Infections occurred more frequently in males (66.7%). In univariate analysis, risk increased with cardiac resynchronization therapy implantation (OR 2.8), ≥3 leads (OR 2.9), early re-intervention (OR 3.6), and pocket hematoma (OR 5.4). Procedure duration was significantly longer in the infection group (p<0.001). In multivariate analysis, hematoma and longer procedure time remained independent predictors of infection (p<0.01). Cox regression among redo procedures identified the number of leads, early reintervention, hematoma, and low ejection fraction as predictors of earlier infection. Conclusion Hematoma formation and prolonged procedure duration significantly increase device-associated infection risk. Using the simplest device compatible with patient needs, minimizing re-interventions, avoiding unnecessary leads, meticulous bleeding control, and shortening procedural duration may reduce infection rates.
No takes yet. Share an insight, caveat, or question.
Ates et al. (2026) conducted a cohort in Cardiac implantable electronic device infection (n=2,202). Pocket hematoma vs. No pocket hematoma was evaluated on Device-associated infection (OR 5.4, p=<0.01). Among 2,202 device procedures, device-associated infection occurred in 4.8% of patients, with pocket hematoma and prolonged procedure duration remaining independent predictors.
Synapse has enriched 10 related papers. Consider them for comparative context: